Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q1 2018 · 10-Q
Revenue—
Net Income-$7.67M-$7.67MN/M vs Q1 2017 EPS Diluted-$0.88-$0.88N/M vs Q1 2017 Operating Income-$7,677,361N/M Operating Cash Flow-$2,118,887N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 14, 2018 · 44 d after period end